Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues

    NEXT STORY
    Cellectis Reports Clinical Hold Placed on MELANI-01 Study
    PREV STORY
    Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen System
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019

    author_avatar
    NASDAQ Market News

    CUSM Class of 2023 Focused on Service and Healthcare for All

    author_avatar
    NASDAQ Market News

    Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

    author_avatar
    NASDAQ Market News